Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB211494

CD21 Antibody (Bu33), FITC, Novus Biologicals™
SDP

Catalog No. NB211494 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB211494 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB211494 Supplier Novus Biologicals Supplier No. NB10063574F
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

CD21 Monoclonal antibody specifically detects CD21 in Human, Equine samples. It is validated for Flow Cytometry

Specifications

Antigen CD21
Applications Flow Cytometry
Classification Monoclonal
Clone Bu33
Conjugate FITC
Formulation PBS
Gene Alias C3DRSLEB9, CD21, CD21 antigen, Complement C3d receptor, complement component (3d/Epstein Barr virus) receptor 2, complement receptor type 2, Cr2, EBV receptor, Epstein-Barr virus receptor
Host Species Mouse
Immunogen Made to Human CD21
Purification Method Protein G purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Adaptive Immunity, Apoptosis, B Cell Development and Differentiation Markers, Dendritic Cell Markers, Immunology
Primary or Secondary Primary
Gene ID (Entrez) 1380
Target Species Human, Equine
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.